Cogent Biosciences Inc. (COGT)
5.71
-0.08 (-1.38%)
At close: Apr 02, 2025, 3:59 PM
5.41
-5.34%
After-hours: Apr 02, 2025, 06:15 PM EDT
Cogent Biosciences Balance Sheet Statement
Financials in USD. Fiscal year
is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 |
| Cash & Equivalents | 98.17M | 53.23M | 139.89M | 219.68M | 242.19M | 37.42M | 55.67M | 28.27M | 41.32M | 90.48M |
| Short-Term Investments | 188.91M | 212.48M | 119.39M | n/a | n/a | n/a | 22.92M | 12.69M | 27.19M | n/a |
| Long-Term Investments | n/a | 7.46M | n/a | 1.25M | 1.25M | 1.25M | 1.25M | 1.25M | 1.25M | 1.25M |
| Other Long-Term Assets | 4.86M | 4.86M | 4.75M | 3.73M | n/a | 427K | 419K | 1.37M | n/a | n/a |
| Receivables | n/a | n/a | n/a | n/a | n/a | 2M | 1.67M | 830K | 928K | 294K |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 75K | n/a | n/a |
| Other Current Assets | 9.39M | 5.06M | 1.25M | 2.95M | 2.72M | 1.17M | 740K | 75K | n/a | 326K |
| Total Current Assets | 296.47M | 270.77M | 264.97M | 222.63M | 244.91M | 40.59M | 81M | 42.38M | 69.73M | 91.1M |
| Property-Plant & Equipment | 26.56M | 30.34M | 31.1M | 4.48M | 4.75M | 7.15M | 3.25M | 4.11M | 4.56M | 2.42M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 31.43M | 42.67M | 35.84M | 9.46M | 6M | 8.83M | 4.92M | 6.74M | 5.82M | 3.67M |
| Total Assets | 327.9M | 313.44M | 300.81M | 232.09M | 250.92M | 49.42M | 85.93M | 49.12M | 75.55M | 94.77M |
| Account Payables | 12.01M | 10.65M | 5.84M | 3.48M | 732K | 3.18M | 1.52M | 1.35M | 1.45M | 1.4M |
| Deferred Revenue | n/a | n/a | 1.7M | 7.97M | 3.79M | 1.31M | 17.95M | 6.89M | 5.96M | 5.29M |
| Short-Term Debt | 1.56M | n/a | 1.42M | 2.32M | 2.05M | 1.62M | n/a | n/a | n/a | 1.00 |
| Other Current Liabilities | 42.13M | 10.31M | 12.1M | 5.56M | 6.82M | 3.01M | 3.88M | 1.64M | 118K | 606K |
| Total Current Liabilities | 55.71M | 38.17M | 26.85M | 17.08M | 13.09M | 13.25M | 24.95M | 11.19M | 8.74M | 7.29M |
| Long-Term Debt | 15.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | 748K | 906K | 908K | 665K |
| Total Long-Term Liabilities | 15.9M | 17.47M | 18.23M | 831K | 3.15M | 4.41M | 748K | 9.62M | 14.43M | 17.96M |
| Total Liabilities | 71.61M | 55.63M | 45.08M | 17.91M | 16.25M | 17.66M | 25.69M | 20.81M | 23.16M | 25.25M |
| Total Debt | 17.47M | 18.85M | 19.65M | 3.15M | 5.21M | 6.03M | n/a | n/a | n/a | n/a |
| Common Stock | 110K | 86K | 70K | 44K | 32K | 30K | 30K | 10K | 10K | 16K |
| Retained Earnings | -859.48M | -603.62M | -411.21M | -270.97M | -198.7M | -123.89M | -92.06M | -51.34M | -25.85M | -7.72M |
| Comprehensive Income | 447K | 246K | -104K | -0.00 | n/a | 0.00 | -12K | -16K | -24K | -16K |
| Shareholders Equity | 256.29M | 257.8M | 255.74M | 214.18M | 234.67M | 31.76M | 60.23M | 28.3M | 52.39M | 69.52M |
| Total Investments | 188.91M | 219.94M | 119.39M | 1.25M | 1.25M | 1.25M | 22.92M | 12.69M | 27.19M | 1.25M |